会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • BETA-SUBSTITUTED GAMMA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS
    • 经取代的氨基酸氨基酸和类似物作为化学治疗剂
    • US20150218085A1
    • 2015-08-06
    • US14613130
    • 2015-02-03
    • QUADRIGA BIOSCIENCES, INC.
    • BERND JANDELEITWOLF-NICOLAS FISCHERKERRY J. KOLLER
    • C07C229/08C07C271/46C07D257/04C07C309/69C07F9/48
    • A61K31/197A61K31/41A61K31/662A61K47/542C07C229/08C07C229/42C07C237/30C07C239/18C07C239/20C07C271/46C07C309/69C07D257/04C07F9/3264C07F9/48C07F9/4816
    • β-Substituted γ-amino acids, β-substituted γ-amino acid derivatives, and β-substituted γ-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates, capable of passing through the blood-brain barrier, and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres and methods of using the compounds for treating tumors are also disclosed. The β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres exhibit an improved selectivity toward tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres exhibit an increased efficacy on a variety of tumor types.
    • &bgr; - 取代的γ-氨基酸,&被取代的γ-氨基酸衍生物和>取代的γ-氨基酸类似物和(生物)等电点及其作为化学治疗剂的用途。 取代的γ-氨基酸衍生物和取代的γ-氨基酸类似物和(生物)等分子体是选择性LAT1 / 4F2hc底物,能够通过血脑屏障,并且在肿瘤中表现出快速的摄取和保留 表达LAT1 / 4F2hc转运蛋白。 还公开了合成取代的γ-氨基酸衍生物和取代的γ-氨基酸类似物和(生物)等离子体的方法和使用该化合物治疗肿瘤的方法。 取代的γ-氨基酸衍生物和取代的γ-氨基酸类似物和(生物)等分子体对于表达LAT1 / 4F2hc转运蛋白的肿瘤细胞表现出改善的选择性,并且当在体内施用于受试者时积累在癌细胞中 。 取代的γ-氨基酸衍生物和取代的γ-氨基酸类似物和(生物)等分子体对各种肿瘤类型表现出增加的功效。
    • 8. 发明授权
    • Method for producing mono-carboxy-functionalized dialkylphosphinic acids, esters and salts using a vinyl ester of a carboxylic acid and the use thereof
    • 使用羧酸的乙烯基酯制备单羧基官能化的二烷基次膦酸,酯和盐的方法及其用途
    • US08735476B2
    • 2014-05-27
    • US13132153
    • 2009-10-06
    • Michael HillMathias DietzWerner KrauseMartin Sicken
    • Michael HillMathias DietzWerner KrauseMartin Sicken
    • C08K5/5313
    • C09K21/12C07F9/301C07F9/4816C07F9/4866C08K5/5313
    • The invention relates to a method for producing mono-carboxy-functionalized dialkylphosphinic acids, esters and salts using a vinyl ester of a carboxylic acid. The method is characterized by the following steps: a) reacting a phosphinic acid source (I) with olefins (IV) in the presence of a catalyst A to give an alkylphosphinic acid, the salt or the ester (II) thereof, b) reacting the alkylphosphinic acid so obtained, the salt or the ester (II) thereof with a vinyl ester of a carboxylic acid of formula (V) in the presence of a catalyst B to give a mono-functionalized dialkylphosphinic acid derivative (VI) and c) reacting the mono-functionalized dialkylphosphinic acid derivative (VI) so obtained in the presence of a catalyst C to give a mono-functionalized dialkylphosphinic acid derivative (VII) and d) reacting the mono-functionalized dialkylphosphinic acid derivative (VII); with an oxidant or in the presence of a catalyst D to give a mono-carboxy-functionalized dialkylphosphinic acid derivative (III).
    • 本发明涉及使用羧酸的乙烯基酯制备单羧基官能化的二烷基次膦酸,酯和盐的方法。 该方法的特征在于以下步骤:a)在催化剂A存在下使次膦酸源(I)与烯烃(IV)反应,得到烷基次膦酸,其盐或其酯(II),b)使 如此获得的烷基次膦酸,其盐或其酯(II)与式(V)的羧酸的乙烯基酯在催化剂B的存在下反应,得到单官能化的二烷基次膦酸衍生物(Ⅵ)和c) 使在催化剂C存在下得到的单官能化二烷基次膦酸衍生物(Ⅵ)反应,得到单官能化二烷基次膦酸衍生物(Ⅶ),和d)使单官能化二烷基次膦酸衍生物(Ⅶ)反应; 与氧化剂或在催化剂D存在下反应,得到单羧基官能化的二烷基次膦酸衍生物(III)。
    • 10. 发明申请
    • Method for Producing Mono-Aminofunctionalized Dialkylphosphinic Acids and Esters and Salts Thereof by Means of Acrylnitriles and Use Thereof
    • 通过丙烯腈生产单氨基官能化二烷基膦酸及其酯及其盐的方法及用途
    • US20110213078A1
    • 2011-09-01
    • US13127072
    • 2009-10-06
    • Michael HillWerner KrauseMartin Sicken
    • Michael HillWerner KrauseMartin Sicken
    • C08L67/02C07F9/30C07F9/32C07F5/06C07F7/28C08G63/183C08L77/06C08G69/26
    • C07F9/3211C07F9/301C07F9/3264C07F9/4816C07F9/4866C08K5/5313C09K21/12
    • The invention relates to a method for producing mono-aminofunctionalized dialkylphosphinic acids and esters and salts thereof by means of acrylnitriles, characterized in that a) a phosphinic acid source (I) is reacted with olefins (IV) to yield an alkylphosphonic acid, salt or ester (II) thereof in the presence of a catalyst A, b) the thus obtained alkylphosphonic acid, salt or ester (II) thereof is reacted with an acrylnitrile of formula (V) to yield a mono-functionalized dialkylphosphinic acid derivative (VI) in the presence of a catalyst B, and c) the thus obtained mono-functionalized dialkylphosphinic acid derivative (VI) is reacted to yield a mono-aminofunctionalized dialkylphosphinic acid derivative (III) in the presence of a catalyst C or a reduction agent, wherein R1, R2, R3, R4, R5, R6, R7 are the same or different and stand independently of each other, among other things, for H, C1-C18 alkyl, C6-C18 aryl, C6-C18 aralkyl, C6-C18 alkylaryl and X stands for H, C1-C18 alkyl, C6-C18 aryl, C6-C18 aralkyl, C6-C18 alkylaryl, Mg, Ca, Al, Sb, Sn, Ge, Ti, Fe, Zr, Zn, Ce, Bi, Sr, Mn, Cu, Ni, Li, Na, K and/or a protonized nitrogen base, and Y stands for a mineral acid, a carboxylic acid, a Lewis acid or an organic acid, n=an integer or fractional number of 0 to 4 and the catalysts A and C are formed by transition metals, transition metal compounds and/or catalyst systems composed of a transition metal and/or a transition metal compound and at least one ligand, and catalyst B is formed by compounds forming peroxides, peroxo compounds, azo compounds, alkali metals, alkaline earth metals, alkali hydrides, alkaline earth hydrides and/or alkali alcoholates and alkaline earth alcoholates.
    • 本发明涉及一种通过丙烯腈生产单氨基官能化二烷基次膦酸及其酯及其盐的方法,其特征在于a)将次膦酸源(I)与烯烃(Ⅳ)反应,得到烷基膦酸盐或盐 酯(II),b)将由此得到的烷基膦酸,其盐或酯(II)与式(V)的丙烯腈反应,得到单官能化二烷基次膦酸衍生物(Ⅵ) 在催化剂B存在下,和c)将由此得到的单官能化二烷基次膦酸衍生物(Ⅵ)反应,得到单氨基官能化二烷基次膦酸衍生物(Ⅲ),其中催化剂C或还原剂存在下,其中 对于H,C 1 -C 18烷基,C 6 -C 18芳基,C 6 -C 18芳烷基,C 6 -C 18烷基,R 1,R 2,R 3,R 4,R 5,R 6,R 7相同或不同,彼此独立 烷基芳基,X代表H,C1-C18烷基,C6-C 18芳基,C 6 -C 18芳烷基,C 6 -C 18烷基芳基,Mg,Ca,Al,Sb,Sn,Ge,Ti,Fe,Zr,Zn,Ce,Bi,Sr,Mn,Cu,Ni,Li,Na,K 和/或质子化的氮碱,Y表示无机酸,羧酸,路易斯酸或有机酸,n = 0至4的整数或分数,催化剂A和C由过渡金属形成 由过渡金属和/或过渡金属化合物和至少一种配体组成的过渡金属化合物和/或催化剂体系和催化剂B通过形成过氧化物,过氧化合物,偶氮化合物,碱金属,碱土金属, 碱金属氢化物,碱土金属氢化物和/或碱金属醇盐和碱土金属盐。